Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Michael Joner is an interventional cardiologist who has been appointed as Professor in Cardiology at the Deutsches Herzzentrum Muenchen (DHZ) after having served as Chief Executive Officer at CVPath Institute, Gaithersburg, Maryland, USA. Dr. Joner's main research interest is the translation of pathological findings in cardiovascular disease into clinical practice.
He graduated from medical school at University of Wuerzburg, Germany in 2003, followed by a research fellowship in cardiovascular pathology. After that he returned to the DHZ to complete his cardiology and interventional cardiology training. Dr. Joner serves as a member of the European Association of Percutaneous Coronary Intervention and is faculty member of major medical congresses. Research awards received include the Young Investigator Award 2013 at CRT 2013 and an award for the best Habilitation at the Technical University of Munich.

Presentation(s):

• Novel insights from NIRF-IVUS Imaging of Vulnerable Plaque

  Saturday, February 25, 2023
  3:27 PM – 3:35 PM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

• Panel Discussion | Advances of Imaging to Detect Vulnerable Plaque: Can we Trust What we See?

  Saturday, February 25, 2023
  3:51 PM – 4:06 PM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

• LATE-BREAKING TRIALS | SESSION TWO

  Sunday, February 26, 2023
  8:00 AM – 9:00 AM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

• BRS BIODEGRADABE POLYMERS BIOADAPTORS | IS THERE A FUTURE FOR THE TECHNOLOGY?

  Sunday, February 26, 2023
  3:50 PM – 5:18 PM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

• Discussion: Is there a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

  Sunday, February 26, 2023
  4:54 PM – 5:18 PM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

• CARDIOTUBE INTERVIEW: Comparison Of Different Percutaneous Revascularization Timing Strategies In Patients Undergoing Transcatheter Aortic Valve Implantation

  Monday, February 27, 2023
  8:45 AM – 8:55 AM ET

  Disclosure information not submitted.

• Comparison of Different Percutaneous Revascularization Timing Strategies in Patients Undergoing Transcatheter Aortic Valve Implantation

  Tuesday, February 28, 2023
  8:00 AM – 8:10 AM ET

  Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)